^○Yasuyuki Ohta¹, Emi Nomura¹, Noriko Hatanaka¹, Yosuke Osakada¹, Namiko Matsumoto¹, Ryo Sasaki¹, Keiichiro Tsunoda¹, Mami Takemoto¹, Koh Tadokoro¹, Nozomi Hishikawa¹, Yosuke Wakutani², Toru Yamashita¹, Kota Sato¹, Yoshio Omote¹, Koji Abe¹ (1.Department of Neurology, Okayama University, Japan, 2.Department of Neurology, Kurashiki Heisei Hospital)

^○Takenobu Murakami^1,2, Mitsunari Abe³, Amanda Tiksnadi², Ayaka Nemoto⁴, Hitoshi Kubo⁴, Naoto Kobayashi⁵, Hiroshi Ito^4,6, Yasuhiro Hashimoto⁷, Yoshikazu Ugawa^2,8 (1.Neurology, Tottori Prefectural Kousei Hospital, Japan, 2.Neurology, Fukushima Medical University, Japan, 3.Center for Neurological Disorders, Fukushima Medical University, 4.Advanced Clinical Research Center, Fukushima Medical University, 5.Azuma Street Clinic, 6.Radiology, Fukushima Medical University, 7.Biochemistry, Fukushima Medical University, 8.Neuro-regeneration, Fukushima Medical University)

^○Tatsuhiro Terada¹, Tomokazu Obi¹, Tomoyasu Bunai², Takashi Matsudaira^1,2, Etsuji Yoshikawa³, Ichiro Ando³, Masami Futatsubashi³, Hideo Tsukada³, Norihiko Kawaguchi¹, Yasukiyo Araki¹, Yasuomi Ouchi² (1.Department of Neurology, NHO Shizuoka Institute of Epilepsy and Neurological Disorders, Japan, 2.Department of Biofunctional Imaging, Preeminent Medical Photonics Education & Research Center, Hamamatsu University School of Medicine, 3.Central Research Laboratory, Hamamatsu Photonics KK)

^○Makiko Shinomoto¹, Takashi Kasai¹, Harutsugu Takebe², Fukiko Kitani-morii¹, Takuma Ohmichi¹, Toshiki Mizuno¹, Takahiko Tokuda^1,3 (1.Kyoto Prefectural University of Medicine, Department of Neurology, Japan, 2.Kyoto Prefectural University of Medicine, Department for Medical Innovation and Translational Medical Science, 3.Kyoto Prefectural University of Medicine, Department of Molecular Pathobiology of Brain Disease)

^○Taro Yasumoto^1,2,3, Yusaku Takamura⁵, Mayumi Tsuji^2,3, Takahiro Nakayama⁶, Keiko Imamura⁷, Haruhisa Inoue⁷, Shiro Nakamura⁴, Tomio Inoue⁴, Atsushi Kimura^1,2,3, Satoshi Yano¹, Hisao Nishijo⁵, Yuji Kiuchi^2,3, David B Teplow⁸, Kenjiro Ono¹ (1.Department of Neurology, School of Medicine, Showa University, Tokyo, Japan, 2.Pharmacological Research Center, Showa University, Tokyo, Japan, 3.Department of Pharmacology, School of Medicine, Showa University, Tokyo, Japan, 4.Department of Oral Physiology, School of Dentistry, Showa University, Tokyo, Japan, 5.System Emotional Science, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan, 6.World Premier International Research Center Initiative (WPI)-Nano Life Science Institute, Kanazawa University, Kanazawa, Japan, 7.Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan, 8.University of California-Los Angeles, LA, USA)

^○Jun-ichi Satoh¹, Yoshihiro Kino¹, Yuko Saito² (1.Department of Bioinformatics, Meiji Pharmaceutical University, Japan, 2.Department of Laboratory Medicine, National Center Hospital, NCNP)

^○Kentaro Hirao¹, Fumio Yamashita², Akito Tsugawa¹, Haime Rieko¹, Tomohiko Sato¹, Misa Okita¹, Soichiro Shimizu¹, Hidekazu Kanetaka¹, Takahiko Umahara¹, Hirofumi Sakurai¹, Haruo Hanyu¹ (1.Department of Geriatric medicine, Tokyo Medical University Hospital, Tokyo, Japan, 2.Department of Ultrahigh Field MRI, Institute for Biomedical Sciences, Iwate Medical University, Iwate, Japan)

^○Gregory Klein¹, Paul Delmar², Geoffrey A. Kerchner², Carsten Hofmann², Danielle Abi-saab², Smiljana Ristic³, Andrew Davis³, Nicola Voyle³, Hironori Tatsuda⁴, Monika Baudler², Paulo Fontoura², Rachelle Doody⁵ (1.Roche Pharma Research and Early Development, Switzerland, 2.Roche/Genentech Product Development, 3.Roche Products Ltd., 4.Chugai Pharmaceutical Co., Ltd., 5.Genentech, Inc.)